A. Definition and Symptoms
- Fulminant Hepatitis implies Severe Hepatic Failure with Jaundice
- Hepatic Encephalopathy (HE)
- Fulminant (Acute) Hepatitis: HE within 2 weeks of jaundice
- Subfulminant Hepatitis: hepatic encephalopathy within 3 months of jaundice
- Absence of Pre-existing Liver Disease
- Hepatic Encephalopathy
- Neurological dysfunction due to severe liver insufficiency
- Affects consciousness, coordination, brain waves, etc.
B. Causes
- Cirrhosis is most common cause overall, typically chronic progression
- In USA, cirrhosis due to alcoholism is most common
- Chronic hepatitis C virus > hepatitis B virus infections also contribute substantially
- Fulminant Liver Failure is most common acute cause
- In USA, acetaminophen overdose is responsible for about 10% of cases
- In United Kingdom, up to 50% of fulminant liver failure due to acetaminophen
- Hepatitis A virus, or superinfection of HBV with delta virus can causes acute failure
- Anything causing chronic hepatitis may eventually lead to HE
C. Pathophysiology [2]
- A complete understanding is not yet available
- Multiple factors have been implicated
- Central GABA receptor activation (benzodiazepine receptor)
- Endogenous benzodiazepine effects most likely (reversed with flumazenil) [3]
- Ammonia (or other basic toxin) excess
- Failed Detoxification - due to bypassing portal system
- Presence of "false" neurotransmitters due to liver failure
- Accumulation of oxindole, a tryptophan metabolite; strongly sedative and hypotensive
- Overactivation of cerebral glutamate receptors
- Deposition of mangenese in cerebrum
- Factors which precipitate HE in chronic cirrhotic patients affect any of these mechanisms
- Causes of Ammonia Excess
- Increased dietary protein - questionable based on recent data [5]
- Gastrointestinal hemorrhage
- Infection - septic and/or bacterial peritonitis
- Blood transfusion
- Azotemia
- Increased Diffusion of Ammonia across Blood-Brain Barrier: alkalosis
- Reduced Liver Function
- Hypoxia - hepatic underperfusion, blood hypoxia, excessive paracentesis
- Diversion of Portal Blood Flow - portosystemic shunts (spontaneous, elective)
- Progressive Liver Damage - acetaminophen, liver hepatoma, alcoholism
- Other psychoactive drugs
D. Grading System for HE [1]
Grade | Consciousness | Intelect | Neurologic Signs | EEG Abnormalities |
---|
0 | normal | normal | none | none |
1 | normal | normal | on psychometric analysis | none |
2 | abn sleep pattern restlessness | forgetful confusion | tremor,apraxia,agraphia incoordination | triphasic waves (5c/sec) |
3 | somnolent, but arousable | disoreinted | aggressive asterixis, dysarthria, ataxia, hypoactivity | triphasic waves (5c/sec) |
4 | COMA | NONE | Decerebration | Delta Activity |
E. Evaluation and Diagnosis - Laboratory examination with history and physical should reveal cause of encephalopathy
- Multiple contributing factors may be present and add to level of encephalopathy
- Serum ammonia levels correlation moderately (r=0.5-0.6) with severity of encephalopathy [4]
- Rule out contributing metabolic causes
- Search for infection; all patients should have surveillence blood cultures
- Toxin screen (urine and blood) for drugs
- Neurologic examination to elucidate focal signs and symptoms
- Grade as above or using other systems
- Asterixis is classic sign, but only occurs with moderately severe HE
F. Treatment
- Reduce Ammonia Production
- Restriction of dietary protein has not been beneficial in recent studies [5]
- Carbohydrate enemas
- Oral lactulose or lactitol (may use lactose in lactase deficiency)
- Lactulose and sorbitol of questionable benefit in recent studies [5]
- Oral antibiotics - metronidazole, neomycin
- Increase Ammonia Metabolism
- Ornithine aspartate supplementation
- Sodium benzoate
- Phenylacetate
- Zinc supplementation
- Flumazenil (Romazicon®) [3]
- Useful for temporary reversal of HE
- Only available parenterally
- Oral flumazenil may be useful for chronic treatment of severe HE
- Glucocorticoids may improve cirrhotic encephalopathy
- Correction of mangenese deposition in basal ganglia being evaluated
- Liver transplantation is often required
References
- Riordan SM and Williams R. 1997. NEJM. 337(7):473
- Albrecht J and Jones EA. 1999. J Neurol Sci. 170(2):138
- Goulenok C, Bernard B, Cadranel JF, et al. 2002. Aliment Pharmacol Ther. 16:361
- Ong JP, Aggarwal A, Krieger D, et al. 2003. Am J Med. 114(3):188
- Shawcross D and Jalan R. 2005. Lancet. 365(9457):431